| regulation of cell projection organization | GO:0031344 | 206 | 0.906 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.866 | |
| cytokine production | GO:0001816 | 319 | 0.860 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.793 | |
| muscle tissue development | GO:0060537 | 308 | 0.789 | |
| embryonic placenta development | GO:0001892 | 98 | 0.783 | |
| cell adhesion | GO:0007155 | 329 | 0.783 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.782 | |
| circulatory system process | GO:0003013 | 197 | 0.753 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.738 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.729 | |
| blood circulation | GO:0008015 | 195 | 0.722 | |
| chemotaxis | GO:0006935 | 247 | 0.717 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.702 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.683 | |
| leukocyte migration | GO:0050900 | 124 | 0.661 | |
| trunk neural crest cell migration | GO:0036484 | 4 | 0.659 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.641 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.639 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.638 | |
| regulation of system process | GO:0044057 | 200 | 0.636 | |
| cardiac chamber development | GO:0003205 | 108 | 0.627 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.621 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.594 | |
| transforming growth factor beta secretion | GO:0038044 | 1 | 0.594 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.592 | |
| immune effector process | GO:0002252 | 321 | 0.589 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.588 | |
| regulation of tube size | GO:0035150 | 57 | 0.583 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress | GO:0008627 | 2 | 0.577 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.577 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.574 | |
| neuron projection guidance | GO:0097485 | 141 | 0.568 | |
| sa node cell to atrial cardiac muscle cell signalling | GO:0086018 | 4 | 0.567 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.566 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.564 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.558 | |
| cell cell adhesion | GO:0098609 | 41 | 0.555 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.551 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.547 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.546 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.539 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.535 | |
| amine metabolic process | GO:0009308 | 45 | 0.531 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.527 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.521 | |
| angiogenesis | GO:0001525 | 201 | 0.516 | |
| sympathetic neuron projection extension | GO:0097490 | 4 | 0.511 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.504 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.501 | |
| regulation of secretion | GO:0051046 | 274 | 0.500 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.498 | |
| neuron migration | GO:0001764 | 122 | 0.495 | |
| septum primum development | GO:0003284 | 4 | 0.491 | |
| epithelium migration | GO:0090132 | 63 | 0.475 | |
| skeletal system development | GO:0001501 | 356 | 0.475 | |
| regulation of cell migration | GO:0030334 | 219 | 0.466 | |
| artery development | GO:0060840 | 53 | 0.465 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.464 | |
| atrial ventricular junction remodeling | GO:0003294 | 2 | 0.464 | |
| forebrain development | GO:0030900 | 302 | 0.462 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.461 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.457 | |
| tissue remodeling | GO:0048771 | 102 | 0.457 | |
| regulation of cell motility | GO:2000145 | 236 | 0.456 | |
| developmental maturation | GO:0021700 | 193 | 0.455 | |
| regulation of ventricular cardiac muscle cell membrane depolarization | GO:0060373 | 2 | 0.453 | |
| regionalization | GO:0003002 | 337 | 0.451 | Mouse |
| heart morphogenesis | GO:0003007 | 178 | 0.451 | |
| wound healing | GO:0042060 | 157 | 0.448 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.444 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.443 | |
| vasodilation | GO:0042311 | 28 | 0.439 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.439 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.432 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.430 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.428 | |
| blood vessel remodeling | GO:0001974 | 33 | 0.417 | |
| negative regulation of axon extension | GO:0030517 | 19 | 0.415 | |
| ventral trunk neural crest cell migration | GO:0036486 | 4 | 0.414 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.410 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.410 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.409 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.401 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.399 | |
| synapse organization | GO:0050808 | 125 | 0.397 | |
| branching involved in salivary gland morphogenesis | GO:0060445 | 26 | 0.397 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.394 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.393 | |
| sympathetic neuron projection guidance | GO:0097491 | 4 | 0.392 | |
| milk ejection | GO:0060156 | 1 | 0.385 | |
| endocrine system development | GO:0035270 | 98 | 0.382 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.381 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.379 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.377 | |
| ventricular septum morphogenesis | GO:0060412 | 27 | 0.373 | |
| sensory perception | GO:0007600 | 245 | 0.372 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.372 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.371 | |
| cellular homeostasis | GO:0019725 | 240 | 0.371 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.369 | |
| cerebral cortex development | GO:0021987 | 86 | 0.368 | |
| regulation of wound healing | GO:0061041 | 40 | 0.364 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.361 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.361 | |
| lung development | GO:0030324 | 164 | 0.361 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.360 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.357 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.356 | |
| transmembrane transport | GO:0055085 | 412 | 0.356 | |
| muscle contraction | GO:0006936 | 101 | 0.354 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.353 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.352 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.348 | |
| gonadotrophin releasing hormone neuronal migration to the hypothalamus | GO:0021828 | 3 | 0.348 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.347 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.344 | |
| axonogenesis | GO:0007409 | 274 | 0.338 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.336 | |
| tissue migration | GO:0090130 | 68 | 0.333 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.331 | |
| cranial nerve development | GO:0021545 | 41 | 0.330 | |
| epithelial cell migration | GO:0010631 | 63 | 0.329 | |
| somitogenesis | GO:0001756 | 69 | 0.328 | Mouse |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.326 | |
| renal system development | GO:0072001 | 225 | 0.322 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.322 | |
| foramen ovale closure | GO:0035922 | 1 | 0.321 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.320 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.318 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.318 | |
| stem cell proliferation | GO:0072089 | 117 | 0.317 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.316 | |
| cerebral cortex cell migration | GO:0021795 | 44 | 0.315 | |
| endocrine process | GO:0050886 | 39 | 0.312 | |
| forebrain neuron development | GO:0021884 | 30 | 0.312 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.308 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.305 | |
| urogenital system development | GO:0001655 | 261 | 0.303 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.301 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.300 | |
| sa node cell action potential | GO:0086015 | 4 | 0.299 | |
| sprouting angiogenesis | GO:0002040 | 26 | 0.295 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.294 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.293 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.292 | |
| renal vesicle induction | GO:0072034 | 3 | 0.290 | |
| placenta development | GO:0001890 | 140 | 0.290 | |
| stem cell differentiation | GO:0048863 | 268 | 0.290 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.288 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.287 | |
| b cell activation | GO:0042113 | 161 | 0.281 | |
| av node cell to bundle of his cell communication | GO:0086067 | 2 | 0.278 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.277 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.277 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.274 | |
| epithelial tube formation | GO:0072175 | 130 | 0.274 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.273 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.271 | |
| stem cell development | GO:0048864 | 219 | 0.271 | |
| protein secretion | GO:0009306 | 111 | 0.270 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.268 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.267 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.261 | |
| telencephalon development | GO:0021537 | 186 | 0.260 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.259 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.255 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.255 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.254 | |
| regulation of protein localization | GO:0032880 | 231 | 0.252 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.252 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.249 | |
| cardiac epithelial to mesenchymal transition | GO:0060317 | 18 | 0.248 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.247 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.247 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.246 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.245 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902218 | 1 | 0.245 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.244 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.240 | |
| cation homeostasis | GO:0055080 | 212 | 0.240 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.236 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.234 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.234 | |
| ear morphogenesis | GO:0042471 | 118 | 0.234 | |
| regulation of heart rate | GO:0002027 | 36 | 0.232 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.232 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.232 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.232 | |
| cell maturation | GO:0048469 | 127 | 0.232 | |
| inflammatory response | GO:0006954 | 244 | 0.232 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.232 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.231 | |
| oviduct development | GO:0060066 | 3 | 0.229 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.229 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.229 | |
| cell recognition | GO:0008037 | 83 | 0.227 | |
| regulation of transforming growth factor beta secretion | GO:2001201 | 1 | 0.227 | |
| heart contraction | GO:0060047 | 93 | 0.226 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.226 | |
| axon guidance | GO:0007411 | 141 | 0.224 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.221 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.220 | |
| regulation of heart growth | GO:0060420 | 31 | 0.219 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.219 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.219 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.217 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.216 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.214 | |
| cerebral cortex tangential migration using cell axon interactions | GO:0021824 | 3 | 0.214 | |
| positive regulation of muscle tissue development | GO:1901863 | 32 | 0.213 | |
| granulocyte chemotaxis | GO:0071621 | 39 | 0.213 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.212 | |
| regulation of cell migration involved in sprouting angiogenesis | GO:0090049 | 4 | 0.210 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.209 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.207 | |
| axon ensheathment | GO:0008366 | 76 | 0.204 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.202 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.202 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.202 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.201 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.200 | |
| positive regulation of transforming growth factor beta secretion | GO:2001203 | 1 | 0.200 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.199 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.199 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.197 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.197 | |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.197 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.196 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.196 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.195 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.194 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.194 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.194 | |
| cell communication by electrical coupling involved in cardiac conduction | GO:0086064 | 2 | 0.193 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.192 | |
| mesenchyme morphogenesis | GO:0072132 | 32 | 0.192 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.191 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.190 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.188 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.188 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.187 | |
| cardiac muscle tissue growth | GO:0055017 | 37 | 0.186 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.186 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.184 | |
| regulation of anagen | GO:0051884 | 1 | 0.184 | |
| morphogenesis of an epithelial sheet | GO:0002011 | 27 | 0.183 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.183 | |
| segmentation | GO:0035282 | 93 | 0.183 | Mouse |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.183 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.182 | |
| neural crest cell migration involved in autonomic nervous system development | GO:1901166 | 5 | 0.181 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.180 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.179 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.179 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.179 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.177 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.177 | |
| mesonephros development | GO:0001823 | 97 | 0.177 | |
| action potential | GO:0001508 | 78 | 0.175 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.175 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.175 | |
| pituitary gland development | GO:0021983 | 38 | 0.174 | |
| locomotory behavior | GO:0007626 | 195 | 0.174 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.174 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.173 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.172 | |
| cardiac septum development | GO:0003279 | 59 | 0.172 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.170 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.170 | |
| camera type eye development | GO:0043010 | 266 | 0.169 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.169 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.168 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.168 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.167 | |
| kidney development | GO:0001822 | 213 | 0.167 | |
| hypothalamus gonadotrophin releasing hormone neuron development | GO:0021888 | 4 | 0.166 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.166 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.166 | |
| brain morphogenesis | GO:0048854 | 32 | 0.165 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.165 | |
| neural tube development | GO:0021915 | 160 | 0.165 | |
| regulation of immune complex clearance by monocytes and macrophages | GO:0090264 | 2 | 0.165 | |
| blood coagulation | GO:0007596 | 76 | 0.165 | |
| membrane depolarization | GO:0051899 | 64 | 0.165 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.164 | |
| striated muscle contraction | GO:0006941 | 45 | 0.164 | |
| muscle system process | GO:0003012 | 141 | 0.164 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.163 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.162 | |
| blastocyst formation | GO:0001825 | 33 | 0.162 | |
| gland development | GO:0048732 | 330 | 0.162 | |
| pallium development | GO:0021543 | 120 | 0.161 | |
| negative regulation of axon guidance | GO:1902668 | 8 | 0.160 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.160 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.159 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.159 | |
| coronary vasculature development | GO:0060976 | 12 | 0.159 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.158 | |
| nephric duct formation | GO:0072179 | 4 | 0.157 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.157 | |
| tube formation | GO:0035148 | 140 | 0.156 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.156 | |
| endocrine pancreas development | GO:0031018 | 29 | 0.155 | |
| cell chemotaxis | GO:0060326 | 81 | 0.154 | |
| developmental cell growth | GO:0048588 | 84 | 0.154 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.153 | |
| epithelial to mesenchymal transition involved in endocardial cushion formation | GO:0003198 | 10 | 0.152 | |
| neural tube formation | GO:0001841 | 108 | 0.152 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.151 | |
| activation of immune response | GO:0002253 | 138 | 0.151 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.151 | |
| ventricular septum development | GO:0003281 | 42 | 0.151 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.151 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.151 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.150 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.150 | |
| extracellular structure organization | GO:0043062 | 148 | 0.150 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.149 | |
| pancreas development | GO:0031016 | 57 | 0.149 | |
| neural crest cell migration | GO:0001755 | 32 | 0.148 | |
| nephron development | GO:0072006 | 109 | 0.148 | |
| heart process | GO:0003015 | 94 | 0.148 | |
| bone development | GO:0060348 | 120 | 0.147 | |
| synaptic transmission | GO:0007268 | 329 | 0.147 | |
| positive regulation of striated muscle tissue development | GO:0045844 | 31 | 0.147 | |
| trunk segmentation | GO:0035290 | 4 | 0.145 | |
| regulation of membrane depolarization during action potential | GO:0098902 | 1 | 0.145 | |
| hypothalamic tangential migration using cell axon interactions | GO:0021856 | 3 | 0.145 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.144 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.144 | |
| neural crest cell development | GO:0014032 | 48 | 0.143 | |
| regulation of cell size | GO:0008361 | 72 | 0.143 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.142 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.141 | Mouse |
| diencephalon development | GO:0021536 | 63 | 0.140 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.139 | |
| multicellular organism growth | GO:0035264 | 161 | 0.139 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.139 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.138 | |
| glial cell differentiation | GO:0010001 | 131 | 0.138 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.137 | |
| paraxial mesoderm morphogenesis | GO:0048340 | 10 | 0.137 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.137 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.137 | |
| bundle of his development | GO:0003166 | 4 | 0.137 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.136 | |
| regulation of atrial cardiac muscle cell membrane depolarization | GO:0060371 | 5 | 0.136 | |
| regulation of ion transport | GO:0043269 | 215 | 0.135 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.135 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.135 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.134 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.134 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.134 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.134 | |
| gtp metabolic process | GO:0046039 | 144 | 0.133 | |
| cardiac muscle cell proliferation | GO:0060038 | 31 | 0.133 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.132 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.132 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.132 | |
| feeding behavior | GO:0007631 | 62 | 0.131 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.130 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.130 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.130 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.130 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.129 | |
| neuron projection extension | GO:1990138 | 64 | 0.129 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.129 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.129 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.128 | |
| vasoconstriction | GO:0042310 | 27 | 0.128 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.128 | |
| sensory perception of sound | GO:0007605 | 97 | 0.127 | |
| regulation of cardiac muscle cell action potential | GO:0098901 | 1 | 0.127 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.127 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.127 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.126 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.126 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.126 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.125 | |
| retinal ganglion cell axon guidance | GO:0031290 | 18 | 0.125 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.124 | |
| hemostasis | GO:0007599 | 78 | 0.124 | |
| exocrine system development | GO:0035272 | 45 | 0.124 | |
| sensory perception of pain | GO:0019233 | 47 | 0.122 | |
| pattern specification involved in metanephros development | GO:0072268 | 4 | 0.122 | |
| myelination | GO:0042552 | 74 | 0.122 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.121 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.121 | |
| forebrain cell migration | GO:0021885 | 58 | 0.121 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 3 | 0.121 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.121 | |
| male sex differentiation | GO:0046661 | 109 | 0.121 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.120 | |
| regulation of blood vessel endothelial cell migration | GO:0043535 | 12 | 0.120 | |
| ear development | GO:0043583 | 200 | 0.120 | |
| epithelial cell development | GO:0002064 | 159 | 0.119 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.119 | |
| regulation of axon guidance | GO:1902667 | 13 | 0.119 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.119 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.119 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.119 | |
| calcium ion transport | GO:0006816 | 159 | 0.119 | |
| amide transport | GO:0042886 | 138 | 0.118 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 26 | 0.118 | |
| fertilization | GO:0009566 | 127 | 0.118 | |
| norepinephrine epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001994 | 3 | 0.118 | |
| regulation of endothelial cell migration | GO:0010594 | 22 | 0.118 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.117 | |
| regulation of axon extension | GO:0030516 | 43 | 0.117 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.116 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.116 | |
| hypothalamus gonadotrophin releasing hormone neuron differentiation | GO:0021886 | 4 | 0.116 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.116 | |
| columnar cuboidal epithelial cell development | GO:0002066 | 29 | 0.115 | |
| retina vasculature development in camera type eye | GO:0061298 | 17 | 0.115 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.114 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.114 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.114 | |
| memory | GO:0007613 | 58 | 0.114 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.113 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.113 | |
| regulation of protein transport | GO:0051223 | 163 | 0.113 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.113 | |
| metanephric nephron development | GO:0072210 | 34 | 0.112 | |
| t cell proliferation | GO:0042098 | 120 | 0.112 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.112 | |
| myoblast differentiation | GO:0045445 | 52 | 0.112 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.112 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.111 | |
| regulation of defense response | GO:0031347 | 233 | 0.111 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.111 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.111 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.111 | |
| determination of heart left right asymmetry | GO:0061371 | 48 | 0.111 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.110 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.110 | |
| trophectodermal cell differentiation | GO:0001829 | 21 | 0.109 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.109 | |
| organ growth | GO:0035265 | 117 | 0.109 | |
| mitral valve development | GO:0003174 | 4 | 0.108 | |
| neural tube patterning | GO:0021532 | 43 | 0.108 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.107 | |
| kidney epithelium development | GO:0072073 | 121 | 0.107 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.107 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.106 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.105 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.105 | |
| positive regulation of the force of heart contraction by epinephrine norepinephrine | GO:0001997 | 3 | 0.105 | |
| regulation of cell activation | GO:0050865 | 289 | 0.105 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.105 | |
| embryonic placenta morphogenesis | GO:0060669 | 25 | 0.105 | |
| regulation of ossification | GO:0030278 | 112 | 0.105 | |
| endomembrane system organization | GO:0010256 | 147 | 0.105 | |
| hormone secretion | GO:0046879 | 128 | 0.104 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.104 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.104 | |
| response to nutrient levels | GO:0031667 | 109 | 0.104 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.103 | |
| granulocyte migration | GO:0097530 | 43 | 0.102 | |
| positive regulation of t cell proliferation | GO:0042102 | 52 | 0.102 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.102 | |
| enteroendocrine cell differentiation | GO:0035883 | 16 | 0.102 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.101 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.101 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.101 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.101 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.101 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.101 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.101 | |
| blastocyst development | GO:0001824 | 80 | 0.101 | |
| peptide secretion | GO:0002790 | 114 | 0.101 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.100 | |
| cell communication by chemical coupling | GO:0010643 | 2 | 0.100 | |
| type b pancreatic cell differentiation | GO:0003309 | 13 | 0.100 | |
| his purkinje system cell differentiation | GO:0060932 | 2 | 0.100 | |
| dichotomous subdivision of terminal units involved in salivary gland branching | GO:0060666 | 5 | 0.099 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.099 | |
| regulation of cell division | GO:0051302 | 76 | 0.098 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.098 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.098 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.098 | |
| interferon gamma production | GO:0032609 | 67 | 0.097 | |
| regulation of epithelial cell migration | GO:0010632 | 35 | 0.097 | |
| facioacoustic ganglion development | GO:1903375 | 3 | 0.097 | |
| negative regulation of growth | GO:0045926 | 99 | 0.096 | |
| spemann organizer formation | GO:0060061 | 2 | 0.096 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.096 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.096 | |
| response to growth factor | GO:0070848 | 198 | 0.096 | |
| osteoblast development | GO:0002076 | 17 | 0.095 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.095 | |
| response to acid chemical | GO:0001101 | 111 | 0.095 | |
| neuronal action potential | GO:0019228 | 54 | 0.095 | |
| renal system process | GO:0003014 | 48 | 0.094 | |
| bone mineralization | GO:0030282 | 54 | 0.094 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.094 | |
| cognition | GO:0050890 | 149 | 0.094 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.094 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.093 | |